JP2022543666A5 - - Google Patents

Info

Publication number
JP2022543666A5
JP2022543666A5 JP2022507725A JP2022507725A JP2022543666A5 JP 2022543666 A5 JP2022543666 A5 JP 2022543666A5 JP 2022507725 A JP2022507725 A JP 2022507725A JP 2022507725 A JP2022507725 A JP 2022507725A JP 2022543666 A5 JP2022543666 A5 JP 2022543666A5
Authority
JP
Japan
Prior art keywords
pyran
triazole
hydroxymethyl
thio
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022507725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543666A (ja
JP7612662B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072238 external-priority patent/WO2021028336A1/en
Publication of JP2022543666A publication Critical patent/JP2022543666A/ja
Publication of JP2022543666A5 publication Critical patent/JP2022543666A5/ja
Application granted granted Critical
Publication of JP7612662B2 publication Critical patent/JP7612662B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022507725A 2019-08-09 2020-08-07 (ヘテロ)アリール-メチル-チオ-ベータ-d-ガラクトピラノシド誘導体 Active JP7612662B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2019/071416 2019-08-09
EP2019071416 2019-08-09
PCT/EP2020/072238 WO2021028336A1 (en) 2019-08-09 2020-08-07 (hetero)aryl-methyl-thio-beta-d-galactopyranoside derivatives

Publications (3)

Publication Number Publication Date
JP2022543666A JP2022543666A (ja) 2022-10-13
JP2022543666A5 true JP2022543666A5 (cg-RX-API-DMAC7.html) 2023-08-15
JP7612662B2 JP7612662B2 (ja) 2025-01-14

Family

ID=71948599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022507725A Active JP7612662B2 (ja) 2019-08-09 2020-08-07 (ヘテロ)アリール-メチル-チオ-ベータ-d-ガラクトピラノシド誘導体

Country Status (9)

Country Link
US (1) US12404295B2 (cg-RX-API-DMAC7.html)
EP (1) EP4010076B1 (cg-RX-API-DMAC7.html)
JP (1) JP7612662B2 (cg-RX-API-DMAC7.html)
KR (1) KR102854071B1 (cg-RX-API-DMAC7.html)
CN (1) CN114206893A (cg-RX-API-DMAC7.html)
CA (1) CA3147082A1 (cg-RX-API-DMAC7.html)
ES (1) ES2972509T3 (cg-RX-API-DMAC7.html)
TW (1) TWI873165B (cg-RX-API-DMAC7.html)
WO (1) WO2021028336A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102863667B1 (ko) 2019-08-09 2025-09-23 이도르시아 파마슈티컬스 리미티드 (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
WO2022073969A1 (en) 2020-10-06 2022-04-14 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
US12291520B2 (en) 2020-11-02 2025-05-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives
JP7844491B2 (ja) 2021-02-09 2026-04-13 イドルシア・ファーマシューティカルズ・リミテッド ヒドロキシヘテロシクロアルカン-カルバモイル誘導体
WO2022184755A1 (en) 2021-03-03 2022-09-09 Idorsia Pharmaceuticals Ltd Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives
WO2022189459A2 (en) * 2021-03-10 2022-09-15 Galecto Biotech Ab Novel galactoside inhibitor of galectins

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100172D0 (sv) 2001-01-22 2001-01-22 Ulf Nilsson New inhibitors against galectins
SE0401301D0 (sv) * 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
KR102231732B1 (ko) 2012-10-10 2021-03-23 갈렉틴 테라퓨틱스, 인크. 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물
IN2015DN02573A (cg-RX-API-DMAC7.html) 2012-10-31 2015-09-11 Galecto Biotech Ab
EP2919802A4 (en) 2012-11-15 2016-09-14 Univ Tufts METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
CA2970062C (en) * 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
ES2734713T3 (es) 2015-07-06 2019-12-11 Gilead Sciences Inc Moduladores Cot y métodos de utilización de los mismos
US20190367552A1 (en) * 2016-03-04 2019-12-05 Galectin Sciences, Llc Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof
CN109563119A (zh) * 2016-07-12 2019-04-02 格莱克特生物技术公司 半乳糖凝集素的α-D-半乳糖苷抑制剂
CA3062649A1 (en) 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the treatment of systemic insulin resistance disorders and the use thereof
KR102626669B1 (ko) 2017-05-12 2024-01-17 갈랙틴 사이언시즈, 엘엘씨 질환의 예방 및 치료를 위한 화합물 및 이의 용도
US11267811B2 (en) 2017-09-27 2022-03-08 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
WO2019075045A1 (en) 2017-10-11 2019-04-18 Bristol-Myers Squibb Company INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
JP2021501180A (ja) * 2017-10-31 2021-01-14 ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニーGalectin Sciences, LLC 全身インスリン抵抗性障害の治療のためのセレノガラクトシド化合物およびその使用
CN113286632A (zh) 2018-10-15 2021-08-20 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂前药
CN113366007A (zh) 2018-10-15 2021-09-07 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂
US11447517B2 (en) 2018-11-21 2022-09-20 Galecto Biotech Ab Galactoside inhibitor of galectins
US12269819B2 (en) 2019-04-10 2025-04-08 Bristol-Myers Squibb Company Small molecule inhibitors of Galectin-3
JP7674276B2 (ja) 2019-07-03 2025-05-09 ガレクト バイオテック エービー ガレクチンの新規なガラクトシド阻害剤
CA3143078A1 (en) 2019-07-05 2021-01-14 Galecto Biotech Ab Novel galactoside inhibitor of galectins
KR102863667B1 (ko) 2019-08-09 2025-09-23 이도르시아 파마슈티컬스 리미티드 (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
WO2022073969A1 (en) 2020-10-06 2022-04-14 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
US12291520B2 (en) 2020-11-02 2025-05-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives
JP7844491B2 (ja) 2021-02-09 2026-04-13 イドルシア・ファーマシューティカルズ・リミテッド ヒドロキシヘテロシクロアルカン-カルバモイル誘導体
WO2022184755A1 (en) 2021-03-03 2022-09-09 Idorsia Pharmaceuticals Ltd Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives

Similar Documents

Publication Publication Date Title
AU2012313254B2 (en) Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
CN100415736C (zh) 喹啉基丙基哌啶衍生物以及其作为抗微生物剂的应用
JP6254075B2 (ja) カリウムチャネル遮断剤としてのアミン誘導体
JP5129143B2 (ja) Mekインヒビターおよびその使用方法
JP2022543859A5 (cg-RX-API-DMAC7.html)
WO2020103817A1 (zh) TGF-βR1抑制剂及其应用
JP2006525298A (ja) アゼチジンカルボキサミド誘導体及びcb1レセプター媒介障害の治療におけるその使用
TW200825062A (en) Biaryl ether urea compounds
HRP20050045A2 (en) Quinoline derivatives and their use as mycrobacetrial inhibitors
JP2022544248A5 (cg-RX-API-DMAC7.html)
JP2022546029A5 (cg-RX-API-DMAC7.html)
TWI484959B (zh) 抗細菌之喹啉衍生物(一)
JP6413032B2 (ja) 新規dgat2阻害剤
WO2007061862A2 (en) 2-keto-oxazoles as modulators of fatty acid amide hydrolase
CN110997653A (zh) 芳基杂环哌啶酮甲酰肽2受体和甲酰肽1受体激动剂
CN114206893A (zh) (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
JP2024506182A5 (cg-RX-API-DMAC7.html)
JP2007506703A5 (cg-RX-API-DMAC7.html)
JP2010509216A (ja) ヘテロシクリル置換抗高コレステロール血症化合物
JP2006522779A (ja) 4−置換キノリン誘導体、その調製方法、中間体及び医薬組成物
JP2021501183A5 (cg-RX-API-DMAC7.html)
WO2014003124A1 (ja) 新規なアミド誘導体またはその塩
CN109476640B (zh) 双环脯氨酸化合物
JP2010504321A5 (cg-RX-API-DMAC7.html)
TWI396536B (zh) 抗細菌之喹啉衍生物(三)